{"organizations": [], "uuid": "c98baac33659d1a7ffa3b6e1bb80729244b4ae01", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-tasly-pharmas-unit-signs-licensing/brief-tasly-pharmas-unit-signs-licensing-agreement-on-diabetes-medicine-with-eli-lilly-idUSH9N1RB02L", "country": "US", "domain_rank": 408, "title": "BRIEF-Tasly Pharma's Unit Signs Licensing Agreement On Diabetes Medicine With Eli Lilly", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.633, "site_type": "news", "published": "2018-04-03T15:51:00.000+03:00", "replies_count": 0, "uuid": "c98baac33659d1a7ffa3b6e1bb80729244b4ae01"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-tasly-pharmas-unit-signs-licensing/brief-tasly-pharmas-unit-signs-licensing-agreement-on-diabetes-medicine-with-eli-lilly-idUSH9N1RB02L", "ord_in_thread": 0, "title": "BRIEF-Tasly Pharma's Unit Signs Licensing Agreement On Diabetes Medicine With Eli Lilly", "locations": [], "entities": {"persons": [], "locations": [{"name": "hong kong", "sentiment": "none"}], "organizations": [{"name": "eli lilly april", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "tasly pharmaceutical group co ltd", "sentiment": "negative"}, {"name": "brief-tasly pharma", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 3 (Reuters) - Tasly Pharmaceutical Group Co Ltd :\n* SAYS UNIT SIGNS LICENSING AGREEMENT ON DIABETES MEDICINE WITH ELI LILLY Source text in Chinese: bit.ly/2EfkbCp Further company coverage: (Reporting by Hong Kong newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "https://bit.ly/2EfkbCp"], "published": "2018-04-03T15:51:00.000+03:00", "crawled": "2018-04-03T11:35:23.000+03:00", "highlightTitle": ""}